img

Global Dravet Syndrome Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Dravet Syndrome Treatment Market Research Report 2024

Dravet syndrome is a rare, severe form of intractable epilepsy. It occurs due to a mutation in the SCN1A gene, which is required for the proper function of brain cells.
According to Mr Accuracy reports’s new survey, global Dravet Syndrome Treatment market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dravet Syndrome Treatment market research.
Although there is no cure for Dravet syndrome, most treatments aim to reduce seizures. First line anti-seizure medications include clobazam (Onfi, Frisium) and valproic acid (Depakote, Depakene). Second line treatments include stiripentol (Diacomit), topiramate (Topamax), and the ketogenic diet.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dravet Syndrome Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Biocodex
Epygenix Therapeutics
GW Pharmaceuticals
OPKO Health
Zogenix
Segment by Type
First-generation Drug (FGD)
Second-generation Drug (SGD)
Third-generation Drug (TGD)

Segment by Application


Hospital Pharmacy
Retail Pharmacy
E- Commerce
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Dravet Syndrome Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dravet Syndrome Treatment Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 First-generation Drug (FGD)
1.2.3 Second-generation Drug (SGD)
1.2.4 Third-generation Drug (TGD)
1.3 Market by Application
1.3.1 Global Dravet Syndrome Treatment Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 E- Commerce
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dravet Syndrome Treatment Market Perspective (2018-2034)
2.2 Dravet Syndrome Treatment Growth Trends by Region
2.2.1 Global Dravet Syndrome Treatment Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Dravet Syndrome Treatment Historic Market Size by Region (2018-2023)
2.2.3 Dravet Syndrome Treatment Forecasted Market Size by Region (2024-2034)
2.3 Dravet Syndrome Treatment Market Dynamics
2.3.1 Dravet Syndrome Treatment Industry Trends
2.3.2 Dravet Syndrome Treatment Market Drivers
2.3.3 Dravet Syndrome Treatment Market Challenges
2.3.4 Dravet Syndrome Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dravet Syndrome Treatment Players by Revenue
3.1.1 Global Top Dravet Syndrome Treatment Players by Revenue (2018-2023)
3.1.2 Global Dravet Syndrome Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Dravet Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dravet Syndrome Treatment Revenue
3.4 Global Dravet Syndrome Treatment Market Concentration Ratio
3.4.1 Global Dravet Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dravet Syndrome Treatment Revenue in 2024
3.5 Dravet Syndrome Treatment Key Players Head office and Area Served
3.6 Key Players Dravet Syndrome Treatment Product Solution and Service
3.7 Date of Enter into Dravet Syndrome Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dravet Syndrome Treatment Breakdown Data by Type
4.1 Global Dravet Syndrome Treatment Historic Market Size by Type (2018-2023)
4.2 Global Dravet Syndrome Treatment Forecasted Market Size by Type (2024-2034)
5 Dravet Syndrome Treatment Breakdown Data by Application
5.1 Global Dravet Syndrome Treatment Historic Market Size by Application (2018-2023)
5.2 Global Dravet Syndrome Treatment Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Dravet Syndrome Treatment Market Size (2018-2034)
6.2 North America Dravet Syndrome Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Dravet Syndrome Treatment Market Size by Country (2018-2023)
6.4 North America Dravet Syndrome Treatment Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dravet Syndrome Treatment Market Size (2018-2034)
7.2 Europe Dravet Syndrome Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Dravet Syndrome Treatment Market Size by Country (2018-2023)
7.4 Europe Dravet Syndrome Treatment Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dravet Syndrome Treatment Market Size (2018-2034)
8.2 Asia-Pacific Dravet Syndrome Treatment Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Dravet Syndrome Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Dravet Syndrome Treatment Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dravet Syndrome Treatment Market Size (2018-2034)
9.2 Latin America Dravet Syndrome Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Dravet Syndrome Treatment Market Size by Country (2018-2023)
9.4 Latin America Dravet Syndrome Treatment Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dravet Syndrome Treatment Market Size (2018-2034)
10.2 Middle East & Africa Dravet Syndrome Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Dravet Syndrome Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Dravet Syndrome Treatment Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biocodex
11.1.1 Biocodex Company Detail
11.1.2 Biocodex Business Overview
11.1.3 Biocodex Dravet Syndrome Treatment Introduction
11.1.4 Biocodex Revenue in Dravet Syndrome Treatment Business (2018-2023)
11.1.5 Biocodex Recent Development
11.2 Epygenix Therapeutics
11.2.1 Epygenix Therapeutics Company Detail
11.2.2 Epygenix Therapeutics Business Overview
11.2.3 Epygenix Therapeutics Dravet Syndrome Treatment Introduction
11.2.4 Epygenix Therapeutics Revenue in Dravet Syndrome Treatment Business (2018-2023)
11.2.5 Epygenix Therapeutics Recent Development
11.3 GW Pharmaceuticals
11.3.1 GW Pharmaceuticals Company Detail
11.3.2 GW Pharmaceuticals Business Overview
11.3.3 GW Pharmaceuticals Dravet Syndrome Treatment Introduction
11.3.4 GW Pharmaceuticals Revenue in Dravet Syndrome Treatment Business (2018-2023)
11.3.5 GW Pharmaceuticals Recent Development
11.4 OPKO Health
11.4.1 OPKO Health Company Detail
11.4.2 OPKO Health Business Overview
11.4.3 OPKO Health Dravet Syndrome Treatment Introduction
11.4.4 OPKO Health Revenue in Dravet Syndrome Treatment Business (2018-2023)
11.4.5 OPKO Health Recent Development
11.5 Zogenix
11.5.1 Zogenix Company Detail
11.5.2 Zogenix Business Overview
11.5.3 Zogenix Dravet Syndrome Treatment Introduction
11.5.4 Zogenix Revenue in Dravet Syndrome Treatment Business (2018-2023)
11.5.5 Zogenix Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Dravet Syndrome Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of First-generation Drug (FGD)
Table 3. Key Players of Second-generation Drug (SGD)
Table 4. Key Players of Third-generation Drug (TGD)
Table 5. Global Dravet Syndrome Treatment Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Dravet Syndrome Treatment Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Dravet Syndrome Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Dravet Syndrome Treatment Market Share by Region (2018-2023)
Table 9. Global Dravet Syndrome Treatment Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Dravet Syndrome Treatment Market Share by Region (2024-2034)
Table 11. Dravet Syndrome Treatment Market Trends
Table 12. Dravet Syndrome Treatment Market Drivers
Table 13. Dravet Syndrome Treatment Market Challenges
Table 14. Dravet Syndrome Treatment Market Restraints
Table 15. Global Dravet Syndrome Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Dravet Syndrome Treatment Market Share by Players (2018-2023)
Table 17. Global Top Dravet Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dravet Syndrome Treatment as of 2024)
Table 18. Ranking of Global Top Dravet Syndrome Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Dravet Syndrome Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Dravet Syndrome Treatment Product Solution and Service
Table 22. Date of Enter into Dravet Syndrome Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Dravet Syndrome Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Dravet Syndrome Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Dravet Syndrome Treatment Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Dravet Syndrome Treatment Revenue Market Share by Type (2024-2034)
Table 28. Global Dravet Syndrome Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Dravet Syndrome Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Dravet Syndrome Treatment Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Dravet Syndrome Treatment Revenue Market Share by Application (2024-2034)
Table 32. North America Dravet Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America Dravet Syndrome Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Dravet Syndrome Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Dravet Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. Europe Dravet Syndrome Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Dravet Syndrome Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Dravet Syndrome Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 39. Asia-Pacific Dravet Syndrome Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Dravet Syndrome Treatment Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Dravet Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Latin America Dravet Syndrome Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Dravet Syndrome Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Dravet Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Middle East & Africa Dravet Syndrome Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Dravet Syndrome Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 47. Biocodex Company Detail
Table 48. Biocodex Business Overview
Table 49. Biocodex Dravet Syndrome Treatment Product
Table 50. Biocodex Revenue in Dravet Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 51. Biocodex Recent Development
Table 52. Epygenix Therapeutics Company Detail
Table 53. Epygenix Therapeutics Business Overview
Table 54. Epygenix Therapeutics Dravet Syndrome Treatment Product
Table 55. Epygenix Therapeutics Revenue in Dravet Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 56. Epygenix Therapeutics Recent Development
Table 57. GW Pharmaceuticals Company Detail
Table 58. GW Pharmaceuticals Business Overview
Table 59. GW Pharmaceuticals Dravet Syndrome Treatment Product
Table 60. GW Pharmaceuticals Revenue in Dravet Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 61. GW Pharmaceuticals Recent Development
Table 62. OPKO Health Company Detail
Table 63. OPKO Health Business Overview
Table 64. OPKO Health Dravet Syndrome Treatment Product
Table 65. OPKO Health Revenue in Dravet Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 66. OPKO Health Recent Development
Table 67. Zogenix Company Detail
Table 68. Zogenix Business Overview
Table 69. Zogenix Dravet Syndrome Treatment Product
Table 70. Zogenix Revenue in Dravet Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 71. Zogenix Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dravet Syndrome Treatment Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Dravet Syndrome Treatment Market Share by Type: 2024 VS 2034
Figure 3. First-generation Drug (FGD) Features
Figure 4. Second-generation Drug (SGD) Features
Figure 5. Third-generation Drug (TGD) Features
Figure 6. Global Dravet Syndrome Treatment Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Dravet Syndrome Treatment Market Share by Application: 2024 VS 2034
Figure 8. Hospital Pharmacy Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. E- Commerce Case Studies
Figure 11. Others Case Studies
Figure 12. Dravet Syndrome Treatment Report Years Considered
Figure 13. Global Dravet Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 14. Global Dravet Syndrome Treatment Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Dravet Syndrome Treatment Market Share by Region: 2024 VS 2034
Figure 16. Global Dravet Syndrome Treatment Market Share by Players in 2024
Figure 17. Global Top Dravet Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dravet Syndrome Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Dravet Syndrome Treatment Revenue in 2024
Figure 19. North America Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. North America Dravet Syndrome Treatment Market Share by Country (2018-2034)
Figure 21. United States Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Canada Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Dravet Syndrome Treatment Market Share by Country (2018-2034)
Figure 25. Germany Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. France Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. U.K. Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Italy Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Russia Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Nordic Countries Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific Dravet Syndrome Treatment Market Share by Region (2018-2034)
Figure 33. China Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Japan Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. South Korea Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Southeast Asia Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. India Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Australia Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America Dravet Syndrome Treatment Market Share by Country (2018-2034)
Figure 41. Mexico Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Brazil Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa Dravet Syndrome Treatment Market Share by Country (2018-2034)
Figure 45. Turkey Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Saudi Arabia Dravet Syndrome Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Biocodex Revenue Growth Rate in Dravet Syndrome Treatment Business (2018-2023)
Figure 48. Epygenix Therapeutics Revenue Growth Rate in Dravet Syndrome Treatment Business (2018-2023)
Figure 49. GW Pharmaceuticals Revenue Growth Rate in Dravet Syndrome Treatment Business (2018-2023)
Figure 50. OPKO Health Revenue Growth Rate in Dravet Syndrome Treatment Business (2018-2023)
Figure 51. Zogenix Revenue Growth Rate in Dravet Syndrome Treatment Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed